last August the Food and Drug Administration approved the first generics of Vyvanse, a popular medication used to treat both ADHD and binge eating disorder (BED). But now, eight months later ...

Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...

Lisdexamfetamine dimesylate 10mg, 20mg, 30mg, 40mg, 50mg, 60mg; strawberry-flavored. 10 mg – white to off-white round shaped tablet debossed with ‘10’ on one side and ‘S489’ on the other ...

Vyvanse (lisdexamfetamine) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat attention ...

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

Elite has launched Elite's a generic version of Vyvanse (lisdexamfetamine disylate) in dosage strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. Generic Vyvanse is indicated ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...

The Food and Drug Administration decided red dye No. 3 (Red 3) will no longer be allowed in American food and medicine on Jan ...